Evidence map›Paper›PMID 38662280›Full record

ArticleAIDS and behavior2024

Empirical Development of a Behavioral Intervention for African American/Black and Latino Persons with Unsuppressed HIV Viral Load Levels: An Application of the Multiphase Optimization Strategy (MOST) Using Cost-Effectiveness as an Optimization Objective.

Jonathan Feelemyer, R Scott Braithwaite, Qinlian Zhou, Charles M Cleland, Prima Manandhar-Sasaki, Leo Wilton, Amanda Ritchie, Linda M Collins, Marya V Gwadz

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jonathan FeelemyerDepartment of Population Health, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-6617-4992
R Scott BraithwaiteDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Qinlian ZhouDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Charles M ClelandDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Prima Manandhar-SasakiDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Leo WiltonDepartment of Human Development, College of Community and Public Affairs (CCPA), State University of New York at Binghamton, Binghamton, NY, USA.
Amanda RitchieConstance and Martin Silver Center on Data Science and Social Equity, New York University, New York, NY, USA.
Linda M CollinsDepartment of Social and Behavioral Sciences, New York University School of Global Public Health, New York, NY, USA.
Marya V GwadzNew York University Silver School of Social Work, New York, NY, USA.
New York University · USBinghamton University · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Pilot and Mentoring CoreP50DA054039 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDA M COLLINS, SUSAN A MURPHY · 2021 to 2026
$18.2M
Using MOST to optimize an HIV care continuum intervention for vulnerable populationsR01DA040480 · NIDA · NEW YORK UNIVERSITY · PI COLLINS, LINDA M, GWADZ, MARYA · 2016 to 2020
$5.9M
NIDA NIH HHS P30 DA011041NIDA NIH HHS P30DA011041NIDA NIH HHS P50 DA054039NIDA NIH HHS R01 DA040480NIDA NIH HHS R01DA040480
6 · The paper itself

Abstract

We used results from an optimization randomized controlled trial which tested five behavioral intervention components to support HIV antiretroviral adherence/HIV viral suppression, grounded in the multiphase optimization strategy and using a fractional factorial design to identify intervention components with cost-effectiveness sufficiently favorable for scalability. Results were incorporated into a validated HIV computer simulation to simulate longer-term effects of combinations of components on health and costs. We simulated the 32 corresponding long-term trajectories for viral load suppression, health related quality of life (HRQoL), and costs. The components were designed to be culturally and structurally salient. They were: motivational interviewing counseling sessions (MI), pre-adherence skill building (SB), peer mentorship (PM), focused support groups (SG), and patient navigation (short version [NS], long version [NL]. All participants also received health education on HIV treatment. We examined four scenarios: one-time intervention with and without discounting and continuous interventions with and without discounting. In all four scenarios, interventions that comprise or include SB and NL (and including health education) were cost effective (< $100,000/quality-adjusted life year). Further, with consideration of HRQoL impact, maximal intervention became cost-effective enough to be scalable. Thus, a fractional factorial experiment coupled with cost-effectiveness analysis is a promising approach to optimize multi-component interventions for scalability. The present study can guide service planning efforts for HIV care settings and health departments.

Indexed as

Black or African AmericanHispanic or LatinoHIV InfectionsMedication AdherenceMotivational InterviewingViral LoadAdultAnti-HIV AgentsBehavior TherapyCost-Benefit AnalysisCounselingFemaleHumansMaleMiddle AgedPatient NavigationAnti-HIV AgentsBlackCost-effectivenessHIV care continuumHIV viral suppressionLatinoMultiphase optimization strategy (MOST)Optimization randomized controlled trialRacial/ethnic disparities

Identifiers

PMID38662280
PMCPMC11415978
OpenAlexW4395466601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.